Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer

Published:2022-01-01 Issue:1 Volume:8 Page:69
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Chavez-MacGregor Mariana¹²,Lei Xiudong¹,Zhao Hui¹,Scheet Paul³,Giordano Sharon H.¹²

Affiliation:

1. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2785677/jamaoncology_chavezmacgregor_2021_oi_210074_1642642469.00722.pdf

Reference36 articles.

1. Association of Coronavirus Disease 2019 (COVID-19) with myocardial injury and mortality.;Bonow;JAMA Cardiol,2020

2. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.;Richardson;JAMA,2020

3. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection.;Wang;JAMA Oncol,2021

4. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.;de Azambuja;ESMO Open,2020

5. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.;Liang;Lancet Oncol,2020

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussion;2024-09-06

2. Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran;BMC Cancer;2024-09-03

3. COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients;International Journal of Infectious Diseases;2024-09

4. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

5. Disentangling the relationship between cancer mortality and COVID-19 in the US;eLife;2024-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3